Thank you Healthcare Industry Future Growth for including Bionaut Labs in your latest report on AI solutions revolutionizing the pharma industry! Our AI pre-planning software automates the delivery of our micro-robots ensuring simple, consistent and repeatable drug delivery results.
𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚: 𝐀𝐈 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐭𝐨 𝐆𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐒𝐭𝐚𝐠𝐠𝐞𝐫𝐢𝐧𝐠 40.2% 𝐂𝐀𝐆𝐑 Download PDF Brochure@ https://lnkd.in/dk_VrJvE The size of global AI in drug discovery market in terms of revenue was estimated to be worth $0.9 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 40.2% from 2023 to 2028. --> 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: NVIDIA, Exscientia, BenevolentAI, Recursion, Insilico Medicine, Schrödinger, Inc. (US), Microsoft Corporation (US), Google (US), Atomwise Inc. (US), Illumina, Inc. (US), NuMedii, Inc. (US), XtalPi Inc. (US), Iktos (France), Tempus Labs (US), Deep Genomics, Inc. (Canada), Verge Genomics (US), BenchSci (Canada), Insitro (US), Valo Health (US), BPGbio, Inc. (US), IQVIA Inc (US), Labcorp (US), Tencent Holdings Limited (China), Predictive Oncology, Inc. (US), Celsius Therapeutics (US), CytoReason (Israel), Owkin, Inc. (US), Cloud Pharmaceuticals (US), Evaxion Biotech (Denmark), Standigm (South Korea), BIOAGE (US), Envisagenics (US), and Aria Pharmaceuticals, Inc. (US). --> 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐓𝐡𝐢𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲, 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲: AbCellera Bionaut Labs C4X Discovery Ltd Cellarity Chroma Medicine CytoViva, Inc Dotmatics Enara Bio Enlivex Therapeutics (Nasdaq: ENLV) EVE Technologies Pvt. Ltd. Freenome Hummingbird Diagnostics GmbH InSilicoTrials Lark Health Medopad Molecular Templates Neurala PathAI Phantom AI Phenomics Health Predicine Revolution Medicines Sanofi Sernova SomaLogic Syndax Pharmaceuticals Tango Therapeutics Thermo Fisher Scientific Valo Health Vera Therapeutics, Inc. Vial Vir Biotechnology, Inc.